NCT01806870View on ClinicalTrials.gov

Immune Enhancement for Immunological Non-responders to ART

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 15, 2018

Study Completion Date

December 15, 2018

Conditions
HIV
Interventions
DIETARY_SUPPLEMENT

Zinc and SAMe

If a subject has side effects their dose of Zinc will be reduced. SAMe will remain the same dose.

Trial Locations (2)

30033

Atlanta VA Medical Center, Decatur

30308

Grady Hospital- Ponce De Leon Clinic, Atlanta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Emory University

OTHER

NCT01806870 - Immune Enhancement for Immunological Non-responders to ART | Biotech Hunter | Biotech Hunter